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1. Introduction
Molecular interactions including protein-protein, enzyme-substrate, protein-nucleic acid,
drug-protein, and drug-nucleic acid play important roles in many essential biological proc‐
esses, such as signal transduction, transport, cell regulation, gene expression control, enzyme
inhibition, antibody–antigen recognition, and even the assembly of multi-domain proteins.
These interactions very often lead to the formation of stable protein–protein or protein-ligand
complexes that are essential to perform their biological functions. The tertiary structure of
proteins is necessary to understand the binding mode and affinity between interacting
molecules. However, it is often difficult and expensive to obtain complex structures by
experimental methods, such as X-ray crystallography or NMR. Thus, docking computation is
considered an important approach for understanding the protein-protein or protein-ligand
interactions [1-3]. As the number of three-dimensional protein structures determined by
experimental techniques grows —structure databases such as Protein Data.
Bank (PDB) and Worldwide Protein Data Bank (wwPDB) have over 88000 protein structures,
many of which play vital roles in critical metabolic pathways that may be regarded as potential
therapeutic targets — and specific databases containing structures of binary complexes become
available, together with information about their binding affinities, such as in PDBBIND [4],
PLD [5], AffinDB [6] and BindDB [7], molecular docking procedures improve, getting more
importance than ever [8].
Molecular docking is a widely used computer simulation procedure to predict the conforma‐
tion of a receptor-ligand complex, where the receptor is usually a protein or a nucleic acid
molecule and the ligand is either a small molecule or another protein (Figure 1).
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Figure 1. Elements in molecular docking.
The accurate prediction of the binding modes between the ligand and protein is of fundamental
importance in modern structure-based drug design. The most important application of
docking software is the virtual screening, in which the most interesting and promising
molecules are selected from an existing database for further research. This places demands on
the used computational method: it must be fast and reliable. Another application is the research
of molecular complexes.
Since the pioneering work of Kuntz et al. [9] during the early 1980s, significant progress has
been made in docking research to improve the computational speed and accuracy. Over the
last years several important steps beyond this point have been given. Handling efficiently the
flexibility of the protein receptor is currently considered one of the major challenges in the
field of docking. The binding-site location and binding orientation can be greatly influenced
by protein flexibility. In fact, X-ray structure determination of protein–ligand complexes
frequently reveals ligands with a buried surface area in the range of 70–100%, which can only
be achieved as a consequence of protein flexibility [3]. There are many interesting docking
suites and algorithms that have shown significant progress in predicting near-native binding
poses by making use of biophysical and biochemical information combination with bioinfor‐
matics.
2. Theory
Modeling the interaction of two molecules is a complex problem. Many forces are involved in
the intermolecular association, including hydrophobic, van der Waals, or stacking interactions
between aromatic amino acids, hydrogen bonding, and electrostatic forces. Modeling the
intermolecular interactions in a ligand-protein complex is difficult since there are many
degrees of freedom as well as insufficient knowledge of the effect of solvent on the binding
association. The process of docking a ligand to a binding site tries to mimic the natural course
of interaction of the ligand and its receptor via the lowest energy pathway [3]. There are simple
methods for docking rigid ligands with rigid receptors and flexible ligands with rigid recep‐
tors, but general methods of docking considering conformationally flexible ligands and
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receptors are problematic. Docking protocols can be described as a combination of a search
algorithm, and the scoring functions (Figure 2).
Figure 2. Methods used for protein-ligand docking.
The search algorithm should create an optimum number of configurations that include the
experimentally determined binding modes. Although a rigorous searching algorithm would
go through all possible binding modes between the two molecules, this search would be
impractical due to the size of the search space and amount of time it might take to complete.
As a consequence, only a small amount of the total conformational space can be sampled, so
a balance must be reached between the computational expense and the amount of the search
space examined. Some common searching algorithms include molecular dynamics, Monte
Carlo methods, genetic algorithms, fragment-based, point complementary and distance
geometry methods, Tabu, and systematic searches. On the other hand, scoring function
consists of a number of mathematical methods used to predict the strength of the non-covalent
interaction called the binding affinity. In all the computational methodologies, one important
problem is the development of an energy scoring function that can rapidly and accurately
describe the interaction between the protein and ligand. Several reviews on scoring are
available in the literature [10-12].
There are three important applications of scoring functions in molecular docking. First is to
determine the binding mode and site of a ligand on a protein. The second application is to
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predict the absolute binding affinity between protein and ligand. This is particularly important
in lead optimization. The third application, and perhaps the most important one in structure-
based drug design, is to identify the potential drug hits/leads for a given protein target by
searching a large ligand database. Over the course of the last years, different scoring functions
have been developed that exhibit different accuracies and computational efficiencies. Some of
these commonly-used functions are: force-field, empirical, knowledge-based and consensus
scoring.
The protein-ligand docking procedure can be typically divided into two parts: rigid body
docking and flexible docking [9].
1. Rigid Docking. This approximation treats both the ligand and the receptor as rigid and
explores only six degrees of translational and rotational freedom, hence excluding any
kind of flexibility. Most of the docking suites employ rigid body docking procedure as a
first step.
2. Flexible Docking. A more common approach is to model the ligand flexibility while
assuming having a rigid protein receptor, considering thereby only the conformational
space of the ligand. Ideally, however, protein flexibility should also be taken into account,
and some approaches in this regard have been developed. There are three general
categories of algorithms to treat ligand flexibility: systematic methods, random or
stochastic methods, and simulation methods [3]. Due to the large size of proteins and their
multiple degrees of freedom, their flexibility may be the most challenging issue in
molecular docking. The methods to address the flexibility of proteins can be grouped into:
soft docking, side-chain flexibility, molecular relaxation and protein ensemble docking.
They were described by Huang et al [1].
3. Experimental docking procedures
There are a number of excellent reviews of molecular docking methods and a large number of
publications comparing the performance of a variety of molecular docking tools [1-3], [13].
Following, we will describe the four-step procedure adopted in this study to perform the
molecular docking.
3.1. Target selection
Ideally, the target structure should be determined experimentally by either X-ray crystallog‐
raphy or nuclear magnetic resonance, which can be downloaded from PDB; however, docking
has been performed successfully in comparison to homology models or threading. The model
should have good quality. It can be tested using validation software such as Molprobity [14].
After selecting the model, it must be prepared by removing the water molecules from the
cavity, stabilizing charges, filling the missing residues, and generating the side chains, all
according to the available parameters. The receptor should be at this point biologically active
and in the stable state.
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3.2. Ligand selection and preparation
The type of ligands chosen for docking will depend on the goal. It can be obtained from various
databases, e.g. ZINC or/and PubChem, or it can be sketched by means of Chemsketch tool [8].
Often it is necessary to apply filters to reduce the number of molecules to be docked. Examples
include the net charge, molecular weight, polar surface area, solubility, commercial availabil‐
ity, similarity thresholds, pharmacophores, synthetic accessibility, and absorption, distribu‐
tion, metabolism, excretion, and toxicology properties. Many times the researchers design their
own molecules such as those generated by us in the example that will be described in this work
in the section 5.
3.3. Docking
This is the last step, where the ligand is docked onto the receptor and the interactions are
checked. The scoring function generates a score depending on the best selected ligand.
3.4. Evaluating docking results
The success of docking algorithms in predicting a ligand binding pose is normally measured
in terms of the root-mean-square deviation (RMSD) between the experimentally-observed
heavy-atom positions of the ligands and the one(s) predicted by the algorithm. The flexibility
of the system is a major challenge in the search for the correct pose. The number of degrees of
freedom included in the conformational search is a central aspect that determines the searching
efficiency [3]. A good performance is usually considered when the RMSD is less than 2Å.
3.5. Docking software description
There are many algorithms available to assess and rationalize ligand-protein or protein-
protein interactions, and their number is constantly increasing. Speed and accuracy are key
features for obtaining successful results in docking approaches. Several algorithms share
common methodologies with novel extensions focused on obtaining a fast method with accuracy
as high as possible. The most common docking programs include AutoDock [15], DOCK [9],
FlexX [16], GOLD [17], ICM [18], ADAM [19], DARWIN [20], DIVALI [21], and DockVision [22].
4. Application of molecular docking to a particular case — Biopolymers
docked to dengue virus E protein
In the last decades, the incidence of Dengue disease has dramatically increased around the
world. About 2.5 billion persons (two fifth of the world population) are exposed to the risk of
contracting the disease. Every year, dengue virus (DENV) infects more than 50 million people,
with approximately 22 000 fatal cases [23]. The disease is endemic in more than 100 countries
of Africa, America, Oriental Mediterranean, Southeast Asia, and the Western Pacific Ocean
with the last two regions being the most affected by the disease. Before 1970 only nine countries
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suffered from the Hemorrhagic Dengue (HD) epidemics, number that in 1995 was multiplied
for more than four. There are four antigenically distinct, but closely related, serotypes of
dengue virus (DENV), which is a Flavivirus member of the family Flaviviridae [24]. Each
serotype has genotypes, which are virulent at several levels; nevertheless, the factors of
virulence are not totally established [25]. A better understanding of the mechanisms and the
molecules involved in the key steps of the DENV transmission cycle may lead to the identifi‐
cation of new anti-dengue targets [26]. In fact, the presence of two or more serotypes in the
same geographical region implies a growing risk to population of contracting Hemorrhagic
Dengue or Dengue Shock Syndrome (SSD) due to a phenomenon known as the Antibody –
Dependent Enhancement (ADE). As a result, the diagnosis and treatment of dengue disease
has become a world-wide global problem to deal with. The mature DENV virion contains three
structural proteins: capsid protein (C), membrane protein (M), and envelope protein (E). In
particular, the DENV E glycoprotein (51-60 kDa~ 495 aa), found on the viral surface, is
important in the initial attachment of the viral particle to the host cell, as it contains two N-
linked glycosylation sites at Asn-67 and Asn-153. While the glycosylation site at position 153
is conserved in most flaviviruses, the site at position 67 is thought to be unique for dengue
virus. N-linked oligosaccharide side chains on flavivirus E proteins have been associated with
viral morphogenesis, infectivity, and tropism [27, 28]. In addition, E protein is closely associ‐
ated with the lipid envelope containing a cellular receptor-binding site (s) and a fusion peptide
[29]. It can be found in a form of a homodimer on the surface of the mature virion, and inside
the cell, it creates a prM-E heterodimer together with the prM protein. E protein is the principal
component of the virion surface, containing the antigenic determinants (epitopes) responsible
for the neutralization of the virus and the hemagglutination of erythrocytes, inducing thereby
an immunological response in the infected host [29]. On native virions, the elongated three-
domain E molecule is positioned tangentially to the virus envelope in a head-to-tail homodi‐
meric conformation. Upon penetration of the virion into the target cell endosome, E dimers
are converted into stable target-cell membrane-inserted homotrimers that reorient themselves
vertically to promote virus-cell fusion at low pH [30]. Furthermore, there is a great deal of
evidence that E protein contains the majority of molecular markers for pathogenicity. Com‐
paring the nucleotide sequence of the E protein gene in different flaviviruses has demonstrated
a perfect conservation of 12 cysteine residues, which form six disulfide bridges. The structural
model for the E protein was refined by Mandl and co-workers [31], who correlated the
structural properties of different epitopes with disulfide bonds [32].
4.1. Biopolymers as potential adjuvants carriers
The aim of this work is to study the docking of monomers of polyvinylpyrrolidone (PVP),
chitosan (CS), and chitosan-tripropylphosphate-chitosan (CS/TPP/CS) with E protein of
dengue virus in order to use them as potential adjuvant carriers. Given their structure, these
polymers have specific molecular anchor sites that are expected to be exploited to induce
antigenic specificity to the conserved regions of dengue virus. Several authors report that the
E protein produces immunity and confers protection against infection in mice with low levels
of neutralizing antibodies [33-35]. Because of the dual role of its receptors as well as the cell
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entry through membrane fusion, the E protein, apart from being the most exposed protein, is
the main target against which the neutralizing antibodies are produced to inhibit its functions.
At present, the biggest challenge in developing an efficient dengue vaccine is to achieve a life-
long protective immune response to all 4 serotypes (DEN1-4) simultaneously. Although
several vaccines are currently being developed, so far only a chimeric dengue vaccine for live
attenuated yellow fever (YF) has reached stage 3 in clinical trials. The candidate vaccines can
be divided into the following types: (a) live attenuated, (b) DEN-DEN and DEN-YF live
chimeric virus, (c) inactivated whole virus, (d) live recombinant, (e) DNA, and (f) subunit
vaccines [36].
Chitosan is a polycationic polymer comprising of D-glucosamine and N-acetyl-D-glucosamine
linked by β(1,4)-glycosides’ bonds. It is produced by deacetylation of chitin, which is extracted
from the shells of crabs and shrimp. It is a linear, hydrophilic, positively charged, water soluble
biopolymer, can form thin films, hydrogels, porous scaffolds, fibers, and micro and nanopar‐
ticles in mild acidity conditions. As a polycationic polymer, it has a high affinity to associate
macromolecules such as insulin, pDNA, siRNA, heparin, among others, with antigenic
molecules, protecting them in turn from hydrolytic and enzymatic degradation [37].
Polyvinylpyrrolidone (N-vinyl-2-pyrrolidone, PVP) has chemical, physical and physiological
properties which have been exploited in various industries, including but not limited to
medical, pharmaceutical, cosmetic, food, and textile, due to its biological compatibility, low
toxicity, tackiness, resistance to thermal degradation in solutions as well as inert behavior in
salt and acidic solutions [38, 39]. It is a water soluble homopolymer with a wide range of
molecular weights (2.5 to 1.200 kDa), molecules between 12 and 1350 monomers, and end-to-
end distances ranging from 2.3 to 93 nanometers. It is physically and chemically stable; it
tolerates heating and air atmospheres for up to 16 hours at 100 °C, as well as the change of
appearance for 2 months at 24 ° C and 15% HCl. When heated with strong bases such as lithium
carbonate, trisodium phosphate or sodium metasilicate, it generates a precipitate due to the
ring opening and subsequent crosslinking of chains. Yen-Jen et al. studied its effect as a drug
deliverer and intracellular acceptor [40].
4.1.1. Molecular docking
In this work, the molecular docking calculations were performed using the AutoDock
program. In particular, it uses a Lamarckian genetic algorithm (LGA) and a force field function
based approximately on the AMBER force field, which consists of five terms: 1) the 12-6
dispersion term of Lennard-Jones, 2) a 12-10 directional hydrogen bonding term, 3) an
electrostatic Coulomb potential, 4) an entropic term, and 5) one term of desolvation pairs. The
scaling factor of these terms is empirically calibrated using a set of 30 structurally-known
protein-ligand complexes, which affinities have been experimentally determined. The
AutoDock program has become widely used due to its good precision and high versatility;
moreover, the latest version of AutoDock (version 4.0) added flexible functions to the side
chains in the receptor.
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4.1.2. Model preparation
In this study we used the E protein of dengue virus. It consists of a dimer with 394 amino acids
(aa) per monomer and, as mentioned before, it is the main component of the dengue virus
envelope. E protein enters the cell by fusion with the membrane due to a previous conforma‐
tional change produced by a low pH, generating thereby a change of form from dimer to trimer,
in which the fusion peptide between the II and III domains is exposed. When the pH is lower
than 6.3, dimers dissociate from dimer phase, making the I and II domains rotate outwards
and exposing the fusion loop, which interacts with the endosomal membrane of the cell.
Domain III then rotates backwards to pull the I and II domains, which were already bound to
the cell membrane by the fusion peptide, thus attaching the cell membrane with the membrane
of the virus in order to release the RNA [27, 29, 41-45]. It is important to mention that Bressanelli
showed that the virus domains remain at neutral pH but their relative orientation is altered
[27]. For best results during the molecular docking process, we optimize the original model of
the dengue virus protein E (PDB code 1OKE) with a number of refinements and validations
cycles with Phenix and Molprobity programs respectively. Figure 3 shows the corrected model
of the dimer and trimer.
Figure 3. Dengue virus protein E. (A) Dimeric protein after geometric and refining corrections with Phenix program.
(B) Trimeric protein that represents a postfusion state (C) Top view of the trimeric form. Domain I (aa1-52,132-193,280-296) is
in red, domain II (aa52-132, 193-280) in yellow and domain III (aa296-394) in blue color.
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4.1.3. Ligands preparation
To prepare the ligands, we utilized the linear PVP and CS monomers, and CS/TPP/CS chains
(Figure 4). The coordinates of those ligands were obtained using the SMILES program [46].
Figure 4. Ligands used in molecular docking. (A) PVP monomer, (B) CS monomer, and (C) CS/TPP/CS chain.
4.1.4. Molecular docking
Molecular docking was performed by means of the AutoDock program that combines rapid
grid-based energy evaluation and efficient search of torsional freedom. This program uses a
semi-empirical free energy force field to evaluate the conformations during the docking
simulations. The force field is quantified using a large number of protein-inhibitor complexes,
for which the inhibition constants (Ki), are known. The force field evaluates the union in two
steps, first when the ligand and the protein are separated. Then, the intramolecular energies
are estimated for the transition from the unbound state to the protein-ligand bound state. In
the second step, intermolecular energies are evaluated by combining the ligand with the
protein conformations bound to themselves. The force field includes six pairs-wise of evalu‐
ations (Vi) and an estimated loss of conformational entropy after binding (ΔSconf):
∆G = (V boundL -L - VunboundL -L ) + (V boundP -P - VunboundP -P ) + (V boundP -L - VunboundP -L + ∆S conf ) (1)
where L refers to the ligand and P to the “protein” in a ligand-protein docking. Each of the
pair-wise energetic terms includes evaluations for dispersion/repulsion, hydrogen bonding,
electrostatics, and desolvation [47].
The calculations can be summarized in the following four steps: (1) preparation of files using
AutoDockTools coordinates, (2) pre-calculation of atomic affinities by using AutoGrid, (3)
docking of ligands by using AutoDock, and (4) analysis of the results applying AutoDockTools.
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4.2. Results
4.2.1. Amino acids of interest in the dengue virus infection mechanism
In the loop conformation, several amino acids are involved in trimerization of unit E of DENV.
These amino acids are of particular interest since they are allocated in between I and II domains,
the fusion loop of the host cell located between domains II and III, and aa268-270 (kl loop).
Also are important, the loop of fusion to the host cell located between domains II and III, which
subsequently is exposed in the trimer with the aa98-111 fusion peptide, and the C-terminal of
domain III, which holds the protein to the virus membrane. Other important amino acids were
mentioned by Mazumder [48], who made a structural analysis of the dengue virus E protein
of the 4 serotypes in order to find the conserved and exposed sites as well as the epitopes in
the T-cell. In our study, we additionally considered the sites of interest described by Yorgo
Modis [42, 43] (Table 1).
In addition to the ten conserved regions presented in Table 1, we predicted around 740 E
proteins of the 4 serotypes, some of which are included in the same Table 1. Their sequences
were quantified using Shannon's entropy [48] with a variation from 0.3 to 1.1 bits.
Amino acid Dimer configuration Trimer configuration Function
L191,T268-I270 This region is known as kl
loop, without the presence
of the ligand (β-
Octylglucoside, BOG), it
forms a salt bridge and a
hydrogen bond with beta
strand I and j of the
counterpart dimer.
The ligand is present;
however, the kl loop does
not adopt the open
conformation present in
the dimer-ligand pair.
A hinge allowing movement
of domains I and II, as well as
conformational changes
when varying the pH of the
endosome.
V382-G385 C terminal that attaches
domain III to premembrane
(prM) virus.
It combines to create a
trimeric contact with the
other two domains.
It holds and folds the
domains I and II, acting as a
zipper. It is the most variable
region among the 4
serotypes.
D98-G111 The loop is protected
between the domain II and
III; it contains a fusion
peptide that is formed by
hydrophobic residues.
It is exposed only in the
trimeric conformation
during the conformational
changes, and it maintains
its structure.
It is the region of highest
interest since it is the binding
receptor for the host cell. In
the trimeric form it fuses and
binds the cell and virus’s
membranes. It is the most
conserved region among the
4 serotypes.
N37, P207 Exposed. Exposed. Conserved epitope in the 4
serotypes.
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Amino acid Dimer configuration Trimer configuration Function
Q211 D215 Exposed. Not exposed. Conserved epitope in the 4
serotypes.
H244, K246 Not exposed. Exposed. Conserved epitope in the 4
serotypes.
C30,121,105,116,285 and
333
30 hidden, 105 semi-
exposed, 116 hidden, 121
semi-exposed, 285 semi-
exposed, 333 semi-exposed.
All semi-hidden. Disulfide bonds in the 4
serotypes. It provides
structure to the protein.
R9 E368 Salt bridge, conserved
region.
Salt bridge, conserved
region.
Structural stability,
interactions between the
domain I and III.
H144,317 Hydrogen bridges, conserved
region.
Hydrogen bridges,
conserved region.
Structural stability of the
main chain with the opposite
domain.
N67 N153 Interacts with N acetyl-D-
glucosamine (NAG)
Only N67 interacts with
NAG.
Glycosylation sites.
Table 1. Sites of interest identified in the structure of the dengue virus E protein according to Yorgo Modis [42, 43,
48].
The analyzed proteins can be identified as: N8-G14, V24-D42, R73-E79, V97-S102, D192-M196,
V208-W220, V252-H261, G281-C285, E314-T319, E370-G374, and K394-G399; whereas the
hidden amino acids, which change to exposed amino acids in the trimer, can be listed as
follows: M1, H244, K246, G254, G330 and K344; and the exposed residues that remain hidden
include the following: S16, Q52, Q167, S169, P243, D290, Q293, S331 and E343. It is worth
mentioning that we have identified at least 14 conserved negative sites in at least 3 of the 4
serotypes (C3, C60, R73, T189, F213, A267, F306, T319, S376, F392, K394, S424, G445, and V485).
The importance of this discovery relies on the fact that it has demonstrated that the epitopes
with negative sites work better as vaccines than those with positive sites as they are less likely
to change due to their functional restrictions.
4.2.2. Dengue virus E protein — PVP docking
The docking of PVP molecules with the E protein of dengue virus has demonstrated that the
interface of the I and II domain was the most energetically favorable site for the binding (Figure
5). The interaction between protein and ligand takes place by establishing 8 hydrogen bonds
with the Asn124, Lys202, and Asp203 amino acids (Table 2). This region is extremely impor‐
tant for the pivotal role it plays in the conformational changes triggered by low pH, which in
turn is closely related to the infectivity of the virus. In particular, the PVP molecule, which
interacts with aa124,202,203 in the E protein-BOG ligand complex, could act as a blocker of the
kl aa268-270 pitchfork activity, which is responsible for the conformational changes in the E
protein at low pH. In other words, it could inhibit their function to work as a hinge for conforma‐
tional changes due to its proximity to amino acids through steric hindrance, preventing thereby
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the hinge action between the I and II domain, which in turn could stiffen the area. Alternative‐
ly, if BOG ligand is absent, the molecule could be internalized into the hydrophobic pocket and
replace it, but the subsequent molecular prediction simulations would be required to deter‐
mine how it could act in the presence of low pH, in order to find out whether the conformation‐
al changes would appear or be inhibited. The PVP is well-known to be highly stable at acid pH
and high temperatures, so its structural integrity is assured to remain intact; the loop or kl
pitchfork amino acids mutate, resulting in an increase of the pH threshold, at which conforma‐
tional changes occur. It is achieved by replacing long hydrophobic side chains by the short ones.
As the result, the site can be consistently represented as a potential trigger in the virus replica‐
tion cycle and a good candidate to inhibit its function (Figure 5).
PVP molecule Amino acid Distance (Å)
O1 OD1-Asp 203 2.75
O2 OD1-Asp 203 2.44
O3 N-Asp 203 2.64
O3 N-Lys 202 2.58
O4 N-Lys 202 3.37
O4 O-Asn 124 2.92
O5 O-Asn 124 3.32
O5 N-Asn 124 2.87
Table 2. Polar interactions of the PVP molecule with dengue virus E protein.
Figure 5. Dengue virus E protein with PVP ligand. The lower part shows a close up of the docking area.
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4.2.3. Dengue virus E protein — CS docking
The docking of CS molecules in the E protein of dengue virus resulted in the interaction with
the interface of domain I and II of the protein (see Figure 6). The CS ligand binds to seven
amino acids of E protein by ten hydrogen bonds (see Table 3). The elongated CS molecule
settles into a channel formed in the II domain surface of the protein. Additionally, it interacts
with amino acids near the kl hinge or loop of I and II domain interface. There is a remarkable
familiarity between the BOG and NAG complexes. Amino acids-CS molecule interactions,
which are shown in Table 10 (aa65,68,202,249,251,272,273), suggest that the mechanism of
action of this molecule is similar to PVP ligand. Additionally, it is very close to the conserved
region V252-H261 that forms a channel in the 4 serotypes. This finding is of the highest
importance since it could very well serve as a ligand for the 4 serotypes, and it could be even
more useful in the development of a chimera vaccine with the four domains III of E protein,
which would be similar to the chimeric vaccine developed in India at the International Centre
for Genetic Engineering and Bionanotechnology.
CS molecule atom Amino acid atom Distance (Å)
O1 ring 1 O- Lys 202- B 3.47
O1 ring 1 O-Met 272-B 2.97
N ring 2 OG-Ser 273-B 3.24
O1 ring 2 N-Val 251-A 3.14
O1 ring 2 O-Val 251-A 1.97
O3 ring 2 O-Leu 65-A 3.28
O5 ring 2 and O2 ring 3 OD2-Asp 249-A 3.5
O1 ring 3 OG1-Thr 68-A 2.77
N ring 3 OD2-Asp 249-A 2.51
N ring 3 OD1-Asp 249-A 3.33
Table 3. CS molecule interactions with dengue virus E protein.
4.2.4. Dengue virus E protein — CS/TPP/CS docking
In this case, we used the CS and TPP monomers taking into account that the CS units form
bindings by means of 1-4 beta bonds. Similarly to the E protein–PVP docking, the molecular
docking between the CS/TPP/CS ligand and the E protein was carried out between the domains
I and II, although we observed more interactions in the case of PVP monomer. Table 4 and
Figure 7 illustrate seven interactions between the amino acids and the BOG. The CS-TPP-CS
complex interacts with aa49, 124, 126, 200, 202, 203, 271 amino acids, and the docking results
suggest that these three molecules are attracted the most to the area formed by the hydrophobic
pocket, indicating that the latter molecule has a direct interaction with the BOG ligand oxygen.
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CS/TPP molecule atom Amino acid atom Distance (Å)
N ring 1 O-Ser 274 3.43
O3 ring 1 OE2-Glu 49 2.90
O5 ring 1 NE2-Gln 271 3.08
O5 ring 1 OE1-Gln 271 2.66
O5 ring 1 O3-BOG 2.74
O1 TPP1 O-Ser274 3.03
O3 TPP1 O4-BOG 3.14
O1 TPP2 OD1-Asp 203 2.83
O3 TPP2 O4-BOG 3.30
O1 TPP3 O-Lys 202 2.19
O1 TPP3 OD1-Asp 203 3.18
O3 TPP3 NE2-Gln 200 3.43
O4 TPP O-Lys 202 2.51
O1 ring 2 N-Lys 202 2.89
O3 ring 2 ND2-Asn 124 2.89
O3 ring 2 OD1-Asn 124 2.38
O4 ring 2 OE2-Glu 126 2.49
Table 4. Docking of CS/TPP/CS molecule with dengue virus E protein.
Figure 6. Docking of dengue virus E protein with CS ligand. The interaction takes place at an interface between the
two monomers.
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Figure 7. CS/TPP/CS molecule docking with the dengue virus E protein.
5. Conclusions
We have reviewed the key concepts and current experimental procedures, including the recent
advances in protein flexibility, ligand sampling, and scoring function. In addition, challenges
and possible future directions were addressed in this chapter. As an example of protein ligand
study we analyzed the interaction between the dengue virus E protein and Polyvinylpyrroli‐
done and Chitosan biopolymers and we confirmed that PVP, CS, and CS/TPP/CS biopolymers
can fulfill the function of adjuvant carriers in the potential development of a chimeric dengue
vaccine against the 4 serotypes of dengue virus. Furthermore, the ring-shaped molecules have
shown affinity to or preference for a place of vital importance in the virus’s cycle of infection
and replication, which placed us on the path to develop an inhibitor of the aforementioned
conformational changes (see Figures 5-7). Their binding to the E protein is possible due to the
great affinity they present to simulated molecules. However, further analysis of molecular
simulation is required to determine the behavior of the protein without the presence of BOG
ligand or in different environmental conditions in the presence of low pH.
Acknowledgements
This work has been supported by Fomix-Veracruz (2009-128001) and CONACyT-Mexico
(CB2008-105491, CMB).
Protein-Protein and Protein-Ligand Docking
http://dx.doi.org/10.5772/56376
77
Author details
Alejandra Hernández-Santoyo1, Aldo Yair Tenorio-Barajas2, Victor Altuzar2,
Héctor Vivanco-Cid3 and Claudia Mendoza-Barrera2*
*Address all correspondence to: omendoza@uv.mx
1 Instituto de Química, Universidad Nacional Autónoma de México, Mexico, D.F., Mexico
2 Laboratorio de Nanobiotecnología, Centro de Investigación en Micro y Nanotecnología,
Universidad Veracruzana, Boca del Rio, Veracruz, Mexico
3 Instituto de Investigaciones Médico-Biológicas, Universidad Veracruzana, Boca del Río,
Veracruz, Mexico
References
[1] Huang, S. Y, & Zou, X. Advances and challenges in protein-ligand docking. Interna‐
tional Journal of Molecular Sciences (2010). , 11(8), 3016-3034.
[2] Halperin, I, Ma, B, Wolfson, H, & Nussinov, R. Principles of docking: An overview of
search algorithms and a guide to scoring functions. Proteins (2002). , 47(4), 409-443.
[3] Sousa, S. F, Fernandes, P. A, & Ramos, M. J. Protein-ligand docking: current status
and future challenges. Proteins (2006). , 65(1), 15-26.
[4] Wang, R, Fang, X, Lu, Y, Yang, C. Y, & Wang, S. The PDBbind Database: Methodolo‐
gies and updates. Journal of Medicinal Chemistry (2005). , 48(12), 4111-4119.
[5] Puvanendrampillai, D, & Mitchell, J. B. L. D Protein Ligand Database (PLD): addi‐
tional understanding of the nature and specificity of protein-ligand complexes. Bioin‐
formatics (2003). , 19(14), 1856-1857.
[6] Block, P, Sotriffer, CA, Dramburg, I, Klebe, G, & Affin, . : a freely accessible database
of affinities for protein-ligand complexes from the PDB. Nucleic Acids Research 2006;
34 D522-526.
[7] Liu, T, Lin, Y, Wen, X, Jorissen, RN, Gilson, MK, & Binding, . : a web-accessible data‐
base of experimentally determined protein-ligand binding affinities. Nucleic Acids
Research 2007; 35 D198-201.
[8] Dias, R. de Azevedo WF Jr. ((2008). Molecular docking algorithms. Curr Drug Tar‐
gets. Dec; , 9(12), 1040-7.
Protein Engineering - Technology and Application78
[9] Kuntz, I. D, Blaney, J. M, Oatley, S. J, Langridge, R, & Ferrin, T. E. A geometric ap‐
proach to macromolecule-ligand interactions. Journal of Molecular Biology (1982). ,
161(2), 269-88.
[10] Jain, A. N. Scoring functions for protein-ligand docking. Current Protein Peptide Sci‐
ence (2006). , 7(5), 407-20.
[11] Gilson, M. K, & Zhou, H. X. Calculation of protein-ligand binding affinities. Annual
Review of Biophysics and Biomolecular Structure (2007). , 36-21.
[12] Huang, S. Y, Grinter, S. Z, & Zou, X. Scoring functions and their evaluation methods
for protein-ligand docking: recent advances and future directions. Physical Chemis‐
try Chemical Physics (2010). , 12(40), 12899-908.
[13] Taylor, R. D, Jewsbury, P. J, & Essex, J. W. A review of protein-small molecule dock‐
ing methods. Journal of Computer-Aided Molecular Design. (2002). , 16(3), 151-66.
[14] Chen, V. B, & Arendall, W. B. rd, Headd JJ, Keedy DA, Immormino RM, Kapral GJ,
Murray LW, Richardson JS, Richardson DC. MolProbity: all-atom structure valida‐
tion for macromolecular crystallography. Acta Crystallographica Section D: Biologi‐
cal Crystallography. (2010). Pt 1):12-21.
[15] Morris, G. M, Huey, R, Lindstrom, W, Sanner, M. F, Belew, R. K, Goodsell, D. S, &
Olson, A. J. AutoDock4 and AutoDockTools4: Automated docking with selective re‐
ceptor flexibility. Journal of Computational Chemistry (2009). , 16-2785.
[16] Rarey, M, Kramer, B, Lengauer, T, & Klebe, G. A fast flexible docking method using
an incremental construction algorithm. Journal of Molecular Biology (1996). , 261(3),
470-89.
[17] Jones, G, Willett, P, Glen, R. C, Leach, A. R, & Taylor, R. Development and validation
of a genetic algorithm for flexible docking. Journal of Molecular Biology (1997). ,
267(3), 727-748.
[18] Abagyan, R, Totrov, M, & Kuznetsov, D. ICM-A new method for protein modeling
and design: Applications to docking and structure prediction from the distorted na‐
tive conformation. Journal of Computational Chemistry (1994). , 15(5), 488-506.
[19] Mizutani, M. Y, Tomioka, N, & Itai, A. Rational automatic search method for stable
docking models of protein and ligand. J. Mol. Biol. (1994). , 243, 310-326.
[20] Taylor, J. S, & Burnett, R. M. DARWIN: A program for docking flexible molecules.
Proteins (2000). , 41, 173-191.
[21] Clark, K. P. Flexible ligand docking without parameter adjust-ment across four li‐
gand-receptor complexes. J. Comput. Chem. (1995). , 16, 1210-1226.
[22] Hart, T. N, & Read, R. J. A multiple-start Monte Carlo docking method. Proteins
(1992). , 13, 206-222.
Protein-Protein and Protein-Ligand Docking
http://dx.doi.org/10.5772/56376
79
[23] World Health OrganizationWHO: Media Centre, Fact sheets: Dengue and severe
dengue. http://www.who.int/accessed 15 August (2012).
[24] Huang, J. H, Wey, J. J, Sun, Y. C, Chin, C, Chien, L. J, & Wu, Y. C. Antibody respons‐
es to an immunodominant nonstructural 1 synthetic peptide in patients with dengue
fever and dengue hemorrhagic fever. Journal of Medical Virology (1999). , 57(1), 1-8.
[25] Muñoz, M. L, Cisneros, A, Cruz, J, Das, P, Tovar, R, & Ortega, A. Putative dengue
virus receptors from mosquito cells. FEMS Microbiology Letter (1998). , 168(2),
251-258.
[26] Cao-lormeau, V. M. Dengue viruses binding proteins from Aedes aegypti and Aedes
polynesiensis salivary glands. Virology Journal (2009).
[27] Bressanelli, S, et al. Structure of a flavivirus envelope glycoprotein in its low-pH-in‐
duced membrane fusion conformation. The EMBO Journal (2004). , 23(4), 728-738.
[28] Mondotte, J. A, Lozach, P. Y, Amara, A, & Gamarnik, A. V. Essential Role of Dengue
Virus Envelope Protein N Glycosylation at Asparagine-67 during Viral Propagation.
Journal Virology (2007). , 81(13), 7136-7148.
[29] Mukhopadhyay, S, Kuhn, R. J, & Rossman, M. G. A structural perspective of the fla‐
vivirus life cycle. Nature Reviews Microbiology (2005). , 13-22.
[30] Stiasny, K, Allison, S. L, Schalich, J, & Heinz, F. X. Membrane Interactions of the
Tick-Borne Encephalitis Virus Fusion Protein E at Low pH. Journal of Virology
(2002). , 76(8), 3784-3790.
[31] Mandl, C. W, Guirakhoo, F, Holzmann, H, Heinz, F. X, & Kunz, C. Antigenic struc‐
ture of the flavivirus envelope protein E at the molecular level, using tick-borne ence‐
phalitis virus as a model. Journal of Virology (1989). , 63(2), 564-571.
[32] Acosta-bas, C, & Gómez-cordero, I. Biología y métodos diagnósticos del dengue. Re‐
vista Biomedica (2005). , 16-113.
[33] Kelly, E. P, Greene, J. J, King, A. D, & Innis, B. L. Purified dengue 2 virus envelope
glycoprotein aggregates produced by baculovirus are immunogenic in mice. Vaccine
(2000). , 18(23), 2549-2559.
[34] Putnak, R, et al. Immunogenic and protective response in mice immunized with a
purified, inactivated, Dengue-2 virus vaccine prototype made in fetal rhesus lung
cells. The American Journal of Tropical Medicine Hygiene (1996). , 55(5), 504-510.
[35] Staropoli, I, Grenckiel, M. P, Mégret, F, & Deubel, V. Affinity-purified dengue-2 virus
envelope glycoprotein induces neutralizing antibodies and protective immunity in
mice. Vaccine (1997).
[36] Heinz, F. X, & Stiasny, K. Flaviviruses and flavivirus vaccines. Vaccine, (2012). ,
30(29), 4301-4306.
Protein Engineering - Technology and Application80
[37] Sundar, S, Kundu, J, & Kundu, S. C. Biopolimeric nanoparticles. Science and Tech‐
nology of Advanced Materials (2010).
[38] Robinson, B. V, Sullivan, F. M, Borzelleca, J. F, & Schwart, S. L. PVP : a Critical Re‐
view of the Kinetics and Toxicology of Polyvinylprrolidone (Povidone). Chelsea, MI:
Lewis Publishers; (1990).
[39] Buhler, V. Polyvinylpyrrolidone Excipients for Pharmaceuticals: Povidone, Crospovi‐
done, and Copovidone. Berlin, New York: Springer-Verlag; (2005).
[40] Wang, Y. J, Chien, Y. C, Wu, C. H, & Liu, D. M. Magnolol-loaded core-shell hydrogel
nanoparticles: drug release, intracellular uptake, and controlled cytotoxicity for the
inhibition of migration of vascular smooth muscle cells. Molecular Pharmaceutics
(2011). , 8(6), 2339-2349.
[41] Harrison, S. C. The pH sensor for flavivirus membrane fusion. The Journal of Cell Bi‐
ology (2008). , 183(2), 177-179.
[42] Modis, Y, Ogata, S, Clements, D, & Harrison, S. C. Structure of the dengue virus en‐
velope protein after membrane fusion. Nature (2004). , 427-313.
[43] Modis, Y, Ogata, S, Clements, D, & Harrison, S. C. A ligand-binding pocket in the
dengue virus envelope glycoprotein. Proceeding of the National Academic Science of
the United State of America (2003). , 100(12), 6986-6991.
[44] Yu, I. M, Holdaway, H. A, Chipman, P. R, Kuhn, R. J, Rossmann, M. G, & Chen, J.
Association of the pr Peptides with Dengue Virus at Acidic pH Blocks Membrane Fu‐
sion. Journal of Virology (2009). , 83(23), 12101-12107.
[45] Sánchez- San Martin CLiu CY, Kielian M. Dealing with low pH: entry and exit of al‐
phaviruses and flaviviruses. Trends in Microbiology (2009). , 17(11), 514-521.
[46] Weininger, D. SMILES, a Chemical Language and Information System. 1. Introduc‐
tion to Methodology and Encoding Rules. Journal of Chemical Information and
Computational Science (1998). , 28(1), 31-36.
[47] Garrett, M, Morris, D. S. G, & Michael, E. Pique, William “Lindy” Lindstrom, Ruth
Huey, Stefano and W.E.H. Forli, Scott Halliday, Rik Belew and Arthur J. Olson, User
Guide AutoDock Version 4.2, Automated Docking of Flexible Ligands to Flexible Re‐
ceptors. (2010). , 49.
[48] Mazumder, R, Hu, Z. Z, Vinayaka, C. R, & Sagripanti, J. L. Frost SDW, Kosakovsky
P, Wu CH. Computational analysis and identification of amino acid sites in dengue E
proteins relevant to development of diagnostics and vaccines. Virus Genes (2007). ,
35(2), 175-186.
Protein-Protein and Protein-Ligand Docking
http://dx.doi.org/10.5772/56376
81

